Login
Business
Entertainment
World
Health
Environment
Lifestyle
National
Science
Sports
World
Movies
Web Series
Technology
Cricket
Coronavirus
Auto
Ajab Ghazab
Finance
India
International
Religious
Politics
Home Articles Generics
Glenmark launches sitagliptin and its fixed-dose combinations, at affordable price for adults with type 2 diabetes in India \
4 min read
\
\

Glenmark launches sitagliptin and its fixed-dose combinations, at affordable price for adults with type 2 diabetes in India

 08-Jul-2022
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company has introduced 8 different combinations of sitagliptin-based drugs under the brand name SITAZIT® and its variants at affordable prices.
08-Jul-2022 Business
\
Glenmark launches ‘Hello Skin’ – India’s first Whatsapp based chatbot to help patients suffering from fungal infections \
5 min read
\
\

Glenmark launches ‘Hello Skin’ – India’s first Whatsapp based chatbot to help patients suffering from fungal infections

 24-May-2022
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), an innovation-led global pharmaceutical company, has developed a digital patient education tool, 'Hello Skin' in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists), to help patients suffering from Dermatophytosis (Ring Worm or Tinea) in India, to adhere to the recommended treatment duration.
24-May-2022 Business
\
Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent \
2 min read
\
\

Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent

 09-May-2022
Mumbai (Maharashtra) [India], May 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent, the generic version of Enstilar®1 Foam, 0.005 per cent|0.064 per cent, of Leo Pharma AS.
09-May-2022 Business
\
Glenmark receives the ‘India Pharma Innovation of the Year’ Award from the Government of India \
3 min read
\
\

Glenmark receives the ‘India Pharma Innovation of the Year’ Award from the Government of India

 27-Apr-2022
Mumbai (Maharashtra) [India], April 27 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, today received the 'India Pharma Innovation of the Year' Award and was adjudged runners-up in the 'India Pharma CSR of the Year' category, as part of the India Pharma & India Medical Device Awards 2022.
27-Apr-2022 Business
\
Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276 in patients with Advanced Solid Tumors and Hodgkin’s Lymphoma \
3 min read
\
\

Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276 in patients with Advanced Solid Tumors and Hodgkin’s Lymphoma

 11-Apr-2022
Mumbai (Maharashtra) [India] April 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, an innovation-driven, global pharmaceutical company, announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator, Drug Controller General of India (DCGI), to conduct a Phase 1 clinical trial of its novel small-molecule, GRC 54276, a hematopoietic progenitor kinase 1 (HPK1) inhibitor.
11-Apr-2022 Business
\
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg \
3 min read
\
\

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

 21-Mar-2022
Mumbai (Maharashtra) [India], March 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for its Lacosamide Tablets1 USP, 50 mg, 100 mg, 150 mg and 200 mg, the generic version of Vimpat®2 Tablets, 50 mg, 100 mg, 150 mg and 200 mg of UCB, Inc.
21-Mar-2022 Business
\
Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe \
2 min read
\
\

Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe

 17-Jan-2022
Mumbai (Maharashtra) [India], January 17 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the generic version of Lexiscan®1 Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US, Inc.
17-Jan-2022 Business
\
Medimny: Revolutionising SCM in Pharma Industry \
4 min read
\
\

Medimny: Revolutionising SCM in Pharma Industry

 10-Sep-2021
The supply chain is becoming leaner, faster, and more self-sufficient as a result of an unparalleled rate of change driven by the use of technology in life sciences. In order to increase process efficiency, automation has taken place at almost every stage of the supply chain. It is for a fact that blockchain architecture is […]
10-Sep-2021 Lifestyle
\